Why were the CEO, President, Chairman of the board posts removed last night?? Any inside info welcome except the usual unacceptable shareholder attacks..... but a good indication why he should be replaced to avoid any negative impression of leadership. I can't imagine any institutional support welcoming this kind of behavior. His job was to get us Nasdaq listed in 2019/20 and so far not met expectations. We are on GNBT/NGIO 2.0 ....... How about GNBT/NGIO 1.0 status?? ........Altucell, Merck/AE37, Olaregen, MSO, HMO, Patel just to name few. Just started Q3, can't wait for Q2 numbers, hopefully a nice surprise.
I'm still counting on von Hofe, the only energetic voice on the conference call !!
GO GO von Hofe !!!! Sounds like you may have the
CoFix-19 Code !!!!!
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links